Recombinant Bartonella quintana Phenylalanine--tRNA ligase alpha subunit (pheS) is a recombinant protein related to the bacterial species Bartonella quintana . Specifically, it is the alpha subunit of the Phenylalanine--tRNA ligase (also known as Phenylalanyl-tRNA synthetase) . Phenylalanine--tRNA ligase is an enzyme that catalyzes the attachment of phenylalanine to its cognate tRNA molecule . This process is essential for protein biosynthesis, as it ensures the correct incorporation of phenylalanine into polypeptide chains during translation.
Phenylalanine--tRNA ligase, which includes the alpha subunit, plays a crucial role in the accurate translation of genetic information . The enzyme ensures that phenylalanine, an essential amino acid, is correctly attached to its corresponding tRNA molecule before being incorporated into a growing polypeptide chain . This is a critical step in maintaining the fidelity of protein synthesis.
Bartonella quintana is a bacterium known to cause trench fever and bacillary angiomatosis . Understanding the function and characteristics of its proteins, such as PheS, can provide insights into the bacterium's virulence, metabolism, and potential drug targets. For instance, Bartonella quintana has an extraordinarily high hemin requirement for growth compared to other bacterial pathogens .
Recombinant PheS can be utilized in various research applications, including:
Structural studies: Determining the three-dimensional structure of the protein to understand its mechanism of action.
Enzyme assays: Investigating the catalytic activity of the enzyme and its interactions with substrates and inhibitors.
Drug discovery: Identifying compounds that can inhibit the enzyme, potentially leading to the development of new antibacterial agents.
Immunological studies: Using the recombinant protein to generate antibodies for diagnostic or research purposes.
Research on related enzymes and metabolic pathways provides context for understanding the role of PheS:
Phenylalanine Metabolism: PheS is directly involved in phenylalanine metabolism, which is connected to the biosynthesis of phenolic acid derivatives .
Hemin-Binding Proteins: B. quintana's high hemin requirement has led to the study of hemin-binding proteins, offering insights into its unique metabolic needs .
Phenylthiazoles: Research into phenylthiazoles has shown promise in developing antibacterial agents against drug-resistant bacteria .
Flavonoid Biosynthesis: Studies on flavonoid biosynthesis in plants reveal the involvement of various transporter genes and regulatory elements .
KEGG: bqu:BQ00770
STRING: 283165.BQ00770
The Phenylalanine-tRNA ligase alpha subunit (pheS) is a critical component of the enzymatic machinery responsible for aminoacylation in Bartonella quintana. This protein functions as part of the phenylalanyl-tRNA synthetase complex (PheRS), which catalyzes the attachment of phenylalanine to its cognate tRNA molecules during protein synthesis. The enzyme has an EC designation of 6.1.1.20 and is essential for bacterial survival as it ensures the correct incorporation of phenylalanine into growing polypeptide chains during translation . In pathogenic bacteria like B. quintana, the causative agent of trench fever, this protein plays a vital role in maintaining protein synthesis under the varying environmental conditions encountered during the infectious cycle.
E. coli expression systems are generally most effective for producing recombinant B. quintana pheS, as demonstrated by successful expression of the homologous protein from B. bacilliformis . When designing expression constructs, researchers should consider using a full-length protein approach (amino acids 1-361 based on B. bacilliformis homolog) with appropriate fusion tags to aid purification . Expression vectors containing T7 or similar strong promoters with inducible control provide optimal results. Temperature modulation during expression is crucial, as B. quintana naturally transitions between 37°C (human host) and 28°C (body louse vector), with significant gene expression changes occurring at these different temperatures . Expression at lower temperatures (16-28°C) often improves protein solubility and proper folding for this type of bacterial protein.
A multi-step purification strategy typically yields the highest purity for recombinant B. quintana pheS. Based on protocols used for similar proteins:
Initial capture: Affinity chromatography using appropriate tags (His, GST, or other fusion tags determined during the manufacturing process)
Intermediate purification: Ion exchange chromatography to separate based on charge properties
Polishing step: Size exclusion chromatography to remove aggregates and achieve final purity
This approach typically yields purity levels >85% as measured by SDS-PAGE . For analytical applications requiring higher purity, additional steps such as hydroxyapatite chromatography may be necessary. The purified protein should be stored with 5-50% glycerol at -20°C/-80°C to maintain stability, with shelf life typically extending to 6 months for liquid formulations and 12 months for lyophilized preparations .
While pheS is primarily involved in protein synthesis, it may indirectly contribute to B. quintana's adaptation to the hemin-rich environment of the body louse gut. B. quintana has the highest reported in vitro hemin requirement of any bacterium and possesses specific adaptations for hemin acquisition . The relationship between protein synthesis machinery and hemin adaptation may involve several mechanisms:
Stress Response Coordination: Hemin toxicity triggers stress responses that require rapid protein synthesis adaptation, potentially involving pheS regulation.
Specialized Protein Expression: The expression of hemin-handling proteins (such as HbpA) increases in high-hemin environments, placing demands on the translation machinery including pheS .
Regulatory Network Integration: Transcription factors like RpoE, which are upregulated in response to high hemin concentrations, may indirectly influence pheS expression or activity .
Experimental approaches to investigate this relationship should include comparative proteomic analysis of B. quintana grown under varying hemin concentrations, assessment of translation fidelity under hemin stress, and investigation of potential physical interactions between pheS and hemin-binding proteins .
B. quintana pheS represents a potential antimicrobial target due to its essential role in protein synthesis. Several experimental approaches can identify effective inhibitors:
High-throughput Screening (HTS):
In vitro aminoacylation assays using purified recombinant pheS and appropriate tRNA substrates
Fluorescence-based assays measuring ATP consumption or pyrophosphate release
Thermal shift assays to identify compounds that alter protein stability
Structure-based Drug Design:
X-ray crystallography or cryo-EM to determine B. quintana pheS structure
Molecular docking studies using the active site or allosteric pockets
Fragment-based screening focused on the catalytic domain
Validation Approaches:
Growth inhibition assays using B. quintana cultures
Time-kill assays to assess bactericidal versus bacteriostatic effects
Mutation frequency studies to assess resistance development
Selectivity Assessment:
Comparative inhibition studies using human phenylalanyl-tRNA synthetase
Cytotoxicity testing in mammalian cell lines
In silico analysis of structural differences between bacterial and human orthologs
Successful inhibitors would likely target unique structural features of the bacterial pheS while minimizing interaction with the human ortholog.
The optimal storage conditions for maintaining stability and activity of purified recombinant B. quintana pheS require careful consideration of buffer components, temperature, and handling protocols. Based on information from similar recombinant proteins:
Storage Buffer Components:
Base buffer: 20-50 mM Tris-HCl or phosphate buffer (pH 7.0-8.0)
Salt: 100-300 mM NaCl to maintain solubility
Glycerol: 5-50% (final concentration) to prevent freeze damage and maintain stability
Reducing agent: 1-5 mM DTT or 2-mercaptoethanol to protect thiol groups
Optional additives: 0.1-1 mM EDTA to chelate metal ions that could promote oxidation
Temperature Considerations:
Long-term storage: -80°C (preferred) or -20°C
Avoid repeated freeze-thaw cycles as they significantly decrease protein activity
Handling Recommendations:
Centrifuge vials briefly before opening to bring contents to the bottom
Reconstitute lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Divide into single-use aliquots before freezing
Document preparation date and number of freeze-thaw cycles
The typical shelf life is approximately 6 months for liquid preparations at -20°C/-80°C and 12 months for lyophilized formulations .
Optimizing enzymatic assays for B. quintana pheS aminoacylation activity requires careful consideration of multiple parameters:
Assay Components:
Enzyme preparation: Purified recombinant pheS (concentration range: 10-500 nM)
Substrates:
L-phenylalanine (typical range: 0.1-5 mM)
ATP (typical range: 1-5 mM)
tRNA^Phe (either purified from E. coli or in vitro transcribed, 0.5-10 μM)
Buffer conditions:
Detection Methods:
Radioactive assays:
[^14C] or [^3H]-labeled phenylalanine incorporation into tRNA
Filter-binding assay followed by scintillation counting
Non-radioactive alternatives:
Pyrophosphate release coupled to colorimetric/fluorescent detection
HPLC analysis of aminoacylated vs. non-aminoacylated tRNA
Mass spectrometry to detect charged tRNA
Optimization Tips:
Conduct initial enzyme concentration and time-course experiments to establish linear range
Include controls lacking individual components (enzyme, ATP, amino acid, tRNA)
Consider the influence of temperature on enzyme kinetics, as B. quintana experiences different temperatures in its life cycle
Test for potential inhibition by high concentrations of substrates or byproducts
Studying protein-protein interactions involving B. quintana pheS in its native context requires approaches that can detect both stable and transient interactions while maintaining physiological relevance:
In vivo Approaches:
Bacterial Two-Hybrid (B2H) System:
Modified for use in Bartonella or in heterologous hosts like E. coli
Allows detection of direct binary interactions
Can be adapted for screening interaction partners from genomic libraries
Cross-linking coupled with Mass Spectrometry (XL-MS):
Chemical cross-linkers applied to intact B. quintana cells
Preserves native interactions before cell disruption
MS/MS analysis identifies cross-linked peptides and interaction sites
Co-immunoprecipitation from B. quintana lysates:
Requires antibodies against B. quintana pheS or epitope tags
Can identify components of larger complexes
Western blotting or MS to identify co-precipitated proteins
In vitro Approaches:
Surface Plasmon Resonance (SPR):
Real-time binding kinetics between purified pheS and potential partners
Quantitative KD, kon, and koff measurements
Requires purified, functional proteins
Microscale Thermophoresis (MST):
Detects interactions based on changes in thermal mobility
Minimal protein consumption
Can be performed in complex buffers mimicking cellular conditions
Analytical Ultracentrifugation (AUC):
Characterizes complex formation in solution
Provides stoichiometry information
No immobilization required
Specialized Approaches for Bartonella:
Evaluate the impact of hemin concentration on protein complexes
Account for membrane association when studying interactions involving membrane-proximal proteins
For pheS specifically, researchers should focus on interactions with the beta subunit (pheT), other translation machinery components, and potential regulatory factors that might respond to environmental signals encountered by B. quintana during its lifecycle.
Future research on B. quintana pheS holds significant promise in several key areas:
Pathogenesis Understanding:
Investigating how translation fidelity via pheS contributes to B. quintana adaptation in diverse host environments
Determining whether pheS activity is modulated during infection stages
Exploring potential moonlighting functions beyond aminoacylation, as observed with some tRNA synthetases in other pathogens
Therapeutic Development:
Structure-guided design of selective inhibitors targeting unique features of B. quintana pheS
Development of attenuated vaccine strains through engineered pheS modifications
Exploration of antimicrobial peptides derived from pheS structural analysis
Diagnostic Applications:
Development of serological tests based on immunogenic epitopes of pheS
Design of nucleic acid amplification tests targeting the pheS gene region
Exploration of pheS as a biomarker for active B. quintana infection
Biotechnology Applications:
Engineering B. quintana pheS for incorporation of non-canonical amino acids
Development of in vitro translation systems optimized for extreme conditions
Exploration of pheS as a potential tool for directed evolution experiments